Most studies discussed in this section were conducted in healthy individuals
References 1) M
Nevertheless, online information tends to be disjointed or ambiguous
Lagares MA, Silva GC, Cortes SF, Moreira FHM, Neves FCD, Alves NDC, Viegas RN, Diniz TF, Lemos VS, Rezende ASC, Freitas MM, Stahlberg R, Nicolino RR
GLP-1 Receptor Agonist Market Size, Share & Industry Analysis, By Drug (Semaglutide, Exenatide, Lixisenatide, Liraglutide, Dulaglutide, and Others), By Route of Administration (Oral and Parenteral), By Age Group (Pediatric and Adults), By Indication (Obesity, Diabetes, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2025-2032
Best for: athletic performance demanding schedules preparation Immune IV High-dose vitamin C and zinc fortifying natural defenses